Literature DB >> 19590308

Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine.

Paul D Mongan1, Paula F Moon-Massat, Virginia Rentko, Shanda Mihok, Anthony Dragovich, Pushpa Sharma.   

Abstract

BACKGROUND: This study determined individual organ blood flows and global hemodynamic, oxygen delivery and consumption parameters after normovolemic exchange transfusions with the hemoglobin based oxygen carrier (HBOC)-201 in a lightly anesthetized swine model.
METHODS: The exchange transfusions were performed as a stepped reduction in blood volume to attain volume exchanges of 10%, 30%, and 50% with a 1:1 replacement with HBOC-201 (n = 8) or oncotically matched 5.9% human serum albumin (HSA, n = 8). Four additional animals served as time controls.
RESULTS: There was no change in the regional blood flows in 8 of 9 organs (brain, heart, kidney, liver, pancreas, gall bladder, small intestines, large intestines, and skeletal muscle) after HBOC-201 compared with controls; only skeletal muscle blood flow decreased. In contrast, with HSA, blood flow increased 150% to 200% of baseline in all organs except muscle where blood flow was unchanged. HBOC-201 effectively restored oxygen delivery after these exchanges. The mean arterial pressure increases in the HBOC-201 group were within 15% to 20% of baseline during the initial 10% exchange and similar to controls during subsequent exchanges. Although peak pulmonary arterial pressure increases in the HBOC-201 group were 10 mm Hg to 15 mm Hg above baseline, cardiac index was unchanged. There were no differences in global oxygen consumption, consistent with unchanged regional blood flow and suggests intact physiologic coupling of oxygen delivery and consumption that was unimpaired by local vasoconstriction. This is in contrast to significant changes of increased cardiac index, decreased arterial pressure, decreased oxygen content, and increased oxygen extraction ratio to maintain normal oxygen consumption in the HSA group.
CONCLUSION: Although the use of HBOC-201 caused alterations in systemic (minimal) and pulmonary (modest) pressures, these changes had no consequence on regional organ blood flow.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590308     DOI: 10.1097/TA.0b013e3181838030

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  6 in total

1.  Ex-Vivo Normothermic Limb Perfusion With a Hemoglobin-Based Oxygen Carrier Perfusate.

Authors:  Sayf A Said; Carlos X Ordeñana; Majid Rezaei; Brian A Figueroa; Srinivasan Dasarathy; Henri Brunengraber; Antonio Rampazzo; Bahar Bassiri Gharb
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

2.  Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model.

Authors:  Bjorn Kyungsuck Song; William H Nugent; Paula F Moon-Massat; Roland N Pittman
Journal:  Microvasc Res       Date:  2014-07-18       Impact factor: 3.514

3.  Vital organ tissue oxygenation after serial normovolemic exchange transfusion with HBOC-201 in anesthetized swine.

Authors:  William W Muir; Govindasamy Ilangovan; Jay L Zweier; Paula F Moon-Massat; Virginia T Rentko
Journal:  Shock       Date:  2011-06       Impact factor: 3.454

4.  NO reactions with sol-gel and solution phase samples of the ferric nitrite derivative of HbA.

Authors:  Camille J Roche; Joel M Friedman
Journal:  Nitric Oxide       Date:  2009-11-15       Impact factor: 4.427

Review 5.  Analysis of energy expenditure in diet-induced obese rats.

Authors:  Houssein Assaad; Kang Yao; Carmen D Tekwe; Shuo Feng; Fuller W Bazer; Lan Zhou; Raymond J Carroll; Cynthia J Meininger; Guoyao Wu
Journal:  Front Biosci (Landmark Ed)       Date:  2014-06-01

Review 6.  New Applications of HBOC-201: A 25-Year Review of the Literature.

Authors:  Min Cao; Yong Zhao; Hongli He; Ruiming Yue; Lingai Pan; Huan Hu; Yingjie Ren; Qin Qin; Xueliang Yi; Tao Yin; Lina Ma; Dingding Zhang; Xiaobo Huang
Journal:  Front Med (Lausanne)       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.